AXIM BIOTECHNOLOGIES, INC. (AXIM) Net income 2015–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$8.1MFY2023 · since FY2015: -$10.1M → -$8.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$8.1M | -191.7% |
| FY2022 | -$2.8M | +82.8% |
| FY2021 | -$16.0M | -150.1% |
| FY2020 | -$6.4M | +0.6% |
| FY2019 | -$6.4M | +4.5% |
| FY2018 | -$6.8M | -62.1% |
| FY2017 | -$4.2M | +28.3% |
| FY2016 | -$5.8M | +42.4% |
| FY2015 | -$10.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AXIM financial trends
AXIM RevenueAXIM Net marginAXIM Gross profitAXIM Gross marginAXIM Operating incomeAXIM Operating marginAXIM Operating cash flowAXIM Free cash flowAXIM Capital expendituresAXIM Return on equityAXIM Stock buybacksAXIM Dividends paidAXIM Total assetsAXIM Total liabilitiesAXIM Shareholders’ equityAXIM overview →